Clinical trials and tribulations

Journal of the Royal Society of Medicine

Volumn 97, Issue 3, 2004, Pages 101-102

  Canter, P H ^a   Ernst, E ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

CLINICAL RESEARCH; CLINICAL TRIAL; DRUG INDUSTRY; DRUG LEGISLATION; DRUG RESEARCH; EDITORIAL; ETHICS; EUROPEAN UNION; FINANCIAL MANAGEMENT; GOOD CLINICAL PRACTICE; GOOD MANUFACTURING PRACTICE; HUMAN; MEDICAL RESEARCH; PROFESSIONAL STANDARD; UNIVERSITY HOSPITAL;

EID: 1642281715     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.97.3.101     Document Type: Editorial

References (4)

1. Chalmers I, Rounding C, Lock K. Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002. BMJ 2003;327:1-4.
2. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Offic J Eur Communities 2001; L121:34-44
3. Woods K. Implementing the European clinical trials directive. BMJ 2004;328:240-1
4. Moulton B. Save European research campaign. BMJ 2004;328:286